CORCEPT THERAPEUTICS INC (CORT) Gross margin 2016–2025
CORCEPT THERAPEUTICS INC (CORT) gross margin by fiscal year — reported gross profit divided by reported revenue.
98.3%FY2025 · since FY2016: 97.5% → 98.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 98.3% | -0.1 pp |
| FY2024 | 98.4% | -0.3 pp |
| FY2023 | 98.7% | -0.0 pp |
| FY2022 | 98.7% | +0.1 pp |
| FY2021 | 98.6% | +0.1 pp |
| FY2020 | 98.4% | +0.2 pp |
| FY2019 | 98.2% | +0.3 pp |
| FY2018 | 97.9% | +0.2 pp |
| FY2017 | 97.8% | +0.3 pp |
| FY2016 | 97.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CORT financial trends
CORT RevenueCORT Net incomeCORT Net marginCORT Gross profitCORT Operating incomeCORT Operating marginCORT Operating cash flowCORT Free cash flowCORT Capital expendituresCORT Return on equityCORT Stock buybacksCORT Dividends paidCORT Total assetsCORT Total liabilitiesCORT Shareholders’ equityCORT overview →